hope against Alzheimer’s disease
Clinical studies conducted on human patients have confirmed laboratory observations. It has been found that individuals with Alzheimer’s disease consistently exhibit significantly lower blood and cellular selenium levels than healthy individuals of the same age. Since the brain is the last organ to lose selenium in the event of a deficiency, but the first to replenish it with supplementation, selenium intake becomes a priority.
A large meta-analysis combining numerous studies evaluated the impact of selenium supplementation on patients with Alzheimer’s disease or mild cognitive impairment. The
